William C. Shakespeare's most recent trade in Theseus Pharmaceuticals Inc was a trade of 21,250 Restricted Stock Units done . Disclosure was reported to the exchange on March 1, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Theseus Pharmaceuticals Inc | William C. Shakespeare | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 21,250 | 21,250 | - | - | Restricted Stock Units | |
Theseus Pharmaceuticals Inc | William C. Shakespeare | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 127,500 | 127,500 | - | - | Stock Option (right to buy) | |
Theseus Pharmaceuticals Inc | William C. Shakespeare | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 180,000 | 180,000 | - | - | Stock Option (right to buy) | |
Theseus Pharmaceuticals Inc | William C. Shakespeare | See Remarks | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 12 Oct 2021 | 625 | 388,949 | - | 16 | 10,000 | Common Stock |